Feed ZTS
Market cap
$32.8B
Enterprise value
$40.6B
P/E
12.5x
Forward P/E
11.3x
PEG
1.6x
P/S
3.4x
P/FCF
13.9x
EV/EBITDA
10.5x
ROIC
21.6%
Gross margin
70.9%
Net margin
27.5%
Dividend yield
2.63%
Payout ratio
33.0%
Net debt/EBITDA
2.0x
Beta
0.74
Free float
99.8%

About the company

Zoetis Inc. (ZTS) is a global pharmaceutical company focused on animal health, headquartered in the USA. The company specializes in the development, manufacturing, and sale of medications and vaccines for animals. Zoetis provides a wide range of products for animal treatment and disease prevention in both domestic pets and livestock. Their portfolio includes medications for animals such as dogs, cats, cattle, pigs, poultry, and others. With its research, innovations, and global presence, Zoetis has gained a leading position in the field of animal health. The company focuses on improving the quality of life for animals and supports animal health worldwide. Zoetis Inc. (ZTS) shares can be an attractive investment opportunity for investors monitoring the animal health sector and valuing stability and long-term growth in this industry.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Kristin C. Peck

Employees

14,500

Headquarters

Parsippany

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

Financial health

Can it carry its debt?

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.